Project ELEVATE initiates clinical trial for development of novel cancer diagnostics
February 10, 2022. Elthera AG, iCellate Medical AB, Targos Molecular Pathology GmbH and Prof. Dr. Susanne Sebens at the Institute of Experimental Cancer Research (IET) at the University of Kiel are proud to announce that the clinical trial for their joint project ELEVATE, funded by the EUREKA Eurstars programme, has commenced.We are excited to enroll the first subject into the ELEVATE clinical trial. Over the next two years, this trial aims to enroll approximately 200 subjects with colorectal or pancreatic cancer, as well as 50 healthy controls. Tumor and liquid biopsy samples will be